Straumann Group (STMN) Q3 2025 earnings summary

Executive summary

• Q3 2025 revenue reached CHF 602.2 million, up 8.3% organically year-over-year; nine-month revenue totaled CHF 2.0 billion, up 9.6% organically.

• EMEA and Latin America delivered strong double-digit organic growth, with EMEA contributing about half of Q3 growth and Latin America over 20%.

• Strategic partnerships and innovation in orthodontics and digital workflows, including Smartee, Dental Monitoring, and the launch of the SIRIOS X3 intraoral scanner, are driving transformation and profitability.

• Shanghai campus fully operational, supporting local production and cost advantages in China.

Financial highlights

• Q3 revenue was CHF 602.2 million (+8.3% organic), with significant negative FX impact and reported growth of 2.9%.

• Regional organic growth: EMEA +11.2%, LATAM +18.0%, NAM +5.7%, APAC +3.2%.

• Tariff mitigation measures reduced expected annual impact to CHF 20–25 million for 2025.

• Full-year currency headwind expected at 470–490 basis points.

Outlook and guidance

• Full-year 2025 guidance confirmed: high single-digit organic revenue growth and 30–60 basis point improvement in core EBIT margin at constant 2024 FX rates.

• Tariff impact for 2026 expected to be similar to 2025, with ongoing mitigation efforts.

• China and APAC expected to face a challenging Q4 and Q1 2026 due to VBP 2.0, but mid-term growth potential remains strong.

• North America expected to continue as a significant growth provider in Q4, with potential for sequential improvement.